Risk of atherosclerosis: Interaction of smoking and glutathione S-transferase genes

Epidemiology

Volumn 14, Issue 3, 2003, Pages 321-327

  Olshan, Andrew F ^a   Li, Rongling ^b   Pankow, James S ^c   Bray, Molly ^f   Tyroler, Herman A ^a   Chambless, Lloyd E ^d   Boerwinkle, Eric ^f   Pittman, Gary S ^a   Bell, Douglas A ^e  

^a IL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^f NONE

Author keywords

Atherosclerosis; Coronary heart disease; Gene environment interaction; GSTM1; GSTT1; Smoking

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; TOBACCO SMOKE; UNCLASSIFIED DRUG; GLUTATHIONE TRANSFERASE;

ADULT; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; B SCAN; CAROTID ARTERY; CIGARETTE SMOKING; ETHNIC GROUP; FEMALE; GENE DELETION; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SMOOTH MUSCLE FIBER; VESSEL; ARTERIOSCLEROSIS; CHROMOSOME DELETION; COHORT ANALYSIS; CORONARY ARTERY DISEASE; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; PROSPECTIVE STUDY;

ARTERIOSCLEROSIS; CHROMOSOME DELETION; COHORT STUDIES; CORONARY DISEASE; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 0037996248     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-200305000-00012     Document Type: Article

References (35)

1. Bogousslavsly J, Regli F, VanMelle G. Risk factors and concomitants of internal carotid artery occlusion or stenosis. Arch Neurol 1985;42:864-867.
2. Gostomzyk JG, Heller WD, Gerhardt P, Lee PN, Keil U. B-scan ultrasound examination of carotid arteries within a representative population (MONICA Project Augsberg). Klin Wochenschr 1988;66(suppl XI):58-65.
3. Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis 1990;81:33-40.
4. Whisnant JP, Homer D, Ingall TJ, Baker HL, O'Fallon WN, Wiebers EXD. Duration of cigarette smoking is the strongest predictor of severe extracranial carotid artery atherosclerosis. Stroke 1990;21:707-714.
5. Tell GS, Polak JF, Ward BJ, Kittner SJ, Savage PJ, Robbins J. Relation of smoking with carotid artery wall thickness and stenosis in older adults. The Cardiovascular Health Study. The Cardiovascular Health Study (CHS) Collaborative Research Group. Circulation 1994;90:2905-2908.
6. Howard G, Burke GL, Szklo M, et al. Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study. Arch Intern Med 1994;154:1277-1282.
7. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
8. Pessah-Rasmussen H, Seidegard J, Stavenow L, Solem JO, Lindblad B, Xu CB. Glutathione transferase activity in human vessels and in cultured arterial smooth muscle cells. Int Angiol 1993;12:348-354.
9. Lapenna D, de Gioia S, Ciofani G, et al. Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation 1998;97:1930-1934.
10. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-743.
11. Benditt EP. Evidence for a monoclonal origin of human atherosclerotic plaques and some implications. Circulation 1974;50:650-652.
12. Penn A, Snydet CA. 1, 3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development. Circulation 1996;93:552-557.
13. De Flora S, Izzotti A, Walsh D, Degan P, Petrilli GL, Lewtas J. Molecular epidemiology of atherosclerosis. FASEB J 1997;11:1021-1031.
14. Zhang Y, Ramos KS. The induction of proliferative vascular smooth muscle cell phenotypes by benzo[a]pyrene does not involve mutational activation of ras genes. Mutat Res 1997;373:285-292.
15. Van Schooten FJ, Hirvonen A, Maas LM, et al. Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue. FASEB J 1998;12:1409-1417.
16. Li R, Boerwinkle E, Olshan AF, et al. Glutathione S-transferase genotype as a susceptibility factor in smoking-related coronary heart disease. Atherosclerosis 2000;149:451-462.
17. Li R, Folsom AR, Sharrett AR, Couper D, Bray M, Tyroler HA. Interaction of the glutathione S-transferase genes and cigarette smoking on risk of lower extremity arterial disease: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2001;154:729-738.
18. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989;129:687-702.
19. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399-1406.
20. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-494.
21. Chambless LE, Zhong MM, Arnett D, Folsom AR, Riley WA, Heiss G. Variability in B-mode ultrasound measurements in the atherosclerosis risk in communities (ARIC) study. Ultrasound Med Biol 1996;22:545-554.
22. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. Woodbury, NY: Cold Spring Harbor Press, 1989; E.3-E.4.
23. The ARIC investigators. Atherosclerosis Risk in Communities Study Protocol 11, Sitting Blood Pressure and Postural Changes in Blood Pressure and Heart Rate. ARIC Coordinating Center, Department of Biostatistics, University of North Carolina 1988.
24. The ARIC Investigators. Atherosclerosis Risk in Communities Study Protocol, Manual 8. Lipid and Lipoprotein Determinations. Chapel Hill, NC: ARIC Coordinating Center, Department of Biostatistics, University of North Carolina, 1988.
25. Software for Survey Data Analysis (SUDAAN) Version 7.5. Research Triangle Park, NC: Research Triangle Institute, 1997.
26. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott-Raven, 1998:340-341.
27. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452-456.
28. Assmann SF, Hosmer DW, Lemeshow S, Mundt KA. Confidence intervals for measures of interaction. Epidemiology 1996;7:286-290.
29. Wilson MH, Grant PJ, Hardie LJ, Wild CP. Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. FASEB J 2000;14:791-796.
30. Truer R, Pemble SE, Kramer H, Taylor JB, Guengerich FP, Ketterer B. Human glutathione S-transferase T1-1 enhances mutagenicity of 1, 2-dibromoethane, dibromomethane and 1, 2, 3, 4-diepoxybutane in Salmonella typhimurium. Carcinogenesis 1996;17:163-166.
31. Kornbrust DJ, Bus JS. The role of glutathione and cytochrome P-450 in the metabolism of methyl chloride. Toxicol Appl Pharmacol 1983;67:246-256.
32. Bogaards JJ, van Ommen B, van Bladeren PJ. Interindividual differences in the in vitro conjugation of methylene chloride with glutathione by cytosolic glutathione S-transferase in 22 human liver samples. Biochem Pharmacol 1993;45:2166-2169.
33. Kelada SN, Kardia SL, Walker AH, Wein AJ, Malkowicz SB, Rebbeck TR. The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol Biomarkers Prev 2000;9:1329-1334.
34. de Waart FG, Kok FJ, Smilde TJ, Hijmans A, Wollersheim H, Stalenhoef AF. Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers. Atherosclerosis 2001;158:227-231.
35. Wang XL, Greco M, Sim AS, Duarte N, Wang J, Wilcken DE. Glutathione S-transferase mul deficiency, cigarette smoking and coronary artery disease. J Cardiovasc Risk 2002;9:25-31.